Head-to-head · Cost-Efficiency Index
Rewinding RX vs TrueMe
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXTrueMe
Cost-first shoppers who want flat all-inclusive GLP-1 pricing, no membership — in its six states.
Visit TrueMeThe verdict
Rewinding RX and TrueMe tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Rewinding RX (ranked #150, a hair above #152) — Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line. But TrueMe is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rewinding RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rewinding RX | TrueMe |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $139/mo (microdose tier, compounded) | $159/mo (compounded) |
| Tirzepatide / mo | $189/mo (microdose tier, compounded) | $189/mo (compounded) |
| Semaglutide / yr (modeled) | $1,668 | $1,908 |
| Tirzepatide / yr (modeled) | $2,268 | $2,268 |
| Coverage | All 50 states | 6 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #150 | #152 |
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
TrueMe
66/100Where the value is
- One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
- Same price at every dose, so the cost does not climb as a provider titrates the dose upward
- Full pricing is published up front — no intake form is required before you can see what you will pay
The tradeoffs
- Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
- Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.